NASDAQ:SGRY - Surgery Partners Stock Price, Forecast & News

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners Inc (NASDAQ:SGRY) announced its earnings results on Tuesday, November, 5th. The company reported ($0.28) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.34) by $0.06. The business earned $452 million during the quarter, compared to analysts' expectations of $452.30 million. Surgery Partners had a negative return on equity of 5.32% and a negative net margin of 11.26%. The company's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter last year, the business posted ($0.19) earnings per share. View Surgery Partners' Earnings History.

Surgery Partners is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Surgery Partners.

Surgery Partners will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

3 brokerages have issued twelve-month price objectives for Surgery Partners' stock. Their forecasts range from $12.00 to $20.00. On average, they expect Surgery Partners' stock price to reach $17.00 in the next twelve months. This suggests that the stock has a possible downside of 10.5%. View Analyst Price Targets for Surgery Partners.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.

Media headlines about SGRY stock have been trending neutral recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Surgery Partners earned a daily sentiment score of 0.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Surgery Partners.

Surgery Partners saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 4,520,000 shares, a decrease of 9.8% from the January 15th total of 5,010,000 shares. Based on an average daily volume of 366,200 shares, the days-to-cover ratio is currently 12.3 days. Approximately 21.9% of the company's stock are short sold. View Surgery Partners' Current Options Chain.

Some companies that are related to Surgery Partners include HCA Healthcare (HCA), Universal Health Services (UHS), Tenet Healthcare (THC), Community Health Systems (CYH) and Quorum Health (QHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Amarin (AMRN), Select Medical (SEM), Visa (V), Editas Medicine (EDIT), Mazor Robotics (MZOR), Xilinx (XLNX) and Bank of America (BAC).

Surgery Partners' stock is owned by many different of retail and institutional investors. Top institutional investors include Royce & Associates LP (2.83%), Goldman Sachs Group Inc. (1.46%), Pictet Asset Management Ltd. (1.29%), State Street Corp (1.00%), Bank of America Corp DE (0.38%) and Marshall Wace LLP (0.37%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Schonfeld Strategic Advisors LLC, Strs Ohio, Royce & Associates LP, Dimension Capital Management LLC, Victory Capital Management Inc., Victory Capital Management Inc. and Credit Suisse AG. View Insider Buying and Selling for Surgery Partners.

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, Marshall Wace LLP, State Street Corp, Public Sector Pension Investment Board, Trexquant Investment LP, California Public Employees Retirement System, Los Angeles Capital Management & Equity Research Inc. and SlateStone Wealth LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SGRY stock can currently be purchased for approximately $19.00.

Surgery Partners has a market capitalization of $949.98 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

The official website for Surgery Partners is http://www.surgerypartners.com/.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]